Biocryst Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
53.93 Mil |
| Income |
-18.53 Mil |
| Net Profit Margin |
-34.36% |
| Return on Equity |
-63.30% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
1.41 |
| Earnings/Share |
-0.48 |
| Book Value/Share |
0.61 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 4.4 | 10.8 | 9.2 |
| 2nd Qtr | 4.8 | 2.7 | 13.4 |
| 3rd Qtr | 10.5 | 8.9 | 20.5 |
| 4th Qtr | NA | 34.2 | 28.2 |
| Total | 19.7 | 56.6 | 71.2 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.24 | -$0.34 | -$0.30 |
| 2nd Qtr | -$0.23 | -$0.33 | -$0.24 |
| 3rd Qtr | -$0.28 | -$0.24 | -$0.32 |
| 4th Qtr | NA | $0.27 | -$0.06 |
| Total | -$0.75 | -$0.64 | -$0.92 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | NA | -467% | --- |
| 2nd Qtr | 4% | 3% | 20% |
| 3rd Qtr | -22% | 27% | -33% |
| 4th Qtr | NA | NA | 81% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 29% | -13% |
| 2nd Qtr | 30% | -38% |
| 3rd Qtr | -17% | 25% |
| 4th Qtr | NA | NA |
advertisement
Recent News